Drugs / NNC 0148-0000-0362
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01597713 | May → Oct 2012 | type 2 diabetes mellitus | Novo Nordisk A/S | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NNC 0148-0000-0362 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01597713 ↗ |
| Route | Oral | “NNC 0148-0000-0362 orally” NCT01597713 ↗ |